Qingdao Kingway Pharmatech is an API and finished-dose manufacturer based in China. It appears in 96 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with EEC_EAEU, HSA (SG) and ISP (CL). Its GMP standing is certified by HSA (SG).
| Site | FDA FEI |
|---|---|
| Las Vegas, United Arab Emirates | Not on file |
| BENSLIMANE, Morocco | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Bisoprolol | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EEC_EAEU | 48 | None |
| HSA (SG) | 24 | 2 |
| ISP (CL) | 12 | None |
| DMP (NO) | 6 | None |
| EDE (AE) | 2 | None |
| MINSA (CR) | 1 | None |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Qingdao Kingway Pharmatech comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.